Schedule 13G ownership disclosure

AnaptysBio Inc

Common Stock, par value $0.001 per share · CUSIP: 032724106

Event date: 2024-12-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Fairmount Funds Management LLC

    Shares: 1,671,484.00 · Class: 5.5%

  • Fairmount Healthcare Fund II L.P.

    Shares: 1,671,484.00 · Class: 5.5%

  • Peter Harwin

    Shares: 1,671,484.00 · Class: 5.5%

  • Tomas Kiselak

    Shares: 1,671,484.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-129775
Form type
SCHEDULE 13G
Filer
ANAPTYSBIO, INC
CIK
CIK 1370053
Filed
Dec 18, 2024
Reporting period
Dec 11, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub